HEXO Corp (HEXO)
0.71
0.00 (0.00%)
USD |
NASDAQ |
Jun 30, 16:00
HEXO Research and Development Expense (Quarterly): 0.0597M for April 30, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| April 30, 2023 | 0.0597M |
| January 31, 2023 | 0.1231M |
| October 31, 2022 | 0.2419M |
| July 31, 2022 | 0.1793M |
| April 30, 2022 | 0.426M |
| January 31, 2022 | 1.166M |
| October 31, 2021 | 0.7689M |
| July 31, 2021 | 0.7601M |
| April 30, 2021 | 0.5795M |
| January 31, 2021 | 0.8826M |
| October 31, 2020 | 0.7811M |
| July 31, 2020 | 0.4949M |
| April 30, 2020 | 0.7401M |
| Date | Value |
|---|---|
| January 31, 2020 | 0.9125M |
| October 31, 2019 | 1.317M |
| July 31, 2019 | 2.124M |
| April 30, 2019 | 0.00 |
| January 31, 2019 | 0.00 |
| October 31, 2018 | 0.00 |
| July 31, 2018 | |
| April 30, 2018 | |
| January 31, 2018 | |
| October 31, 2017 | 0.0491M |
| July 31, 2017 | |
| April 30, 2017 | 0.0288M |
| January 31, 2017 | 0.0109M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
Oct 2018
2.124M
Maximum
Jul 2019
0.6083M
Average
0.5795M
Median
Apr 2021
Research and Development Expense (Quarterly) Benchmarks
| Acasti Pharma Inc | 1.095M |
| Aurinia Pharmaceuticals Inc | 12.65M |
| Edesa Biotech Inc | 1.026M |
| Lexaria Bioscience Corp | 1.641M |
| Liminal Biosciences Inc | 3.226M |